Asmaa Badr
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Asmaa Badr has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Amy Webb
Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA
2 shared publicationsGauruv Gupta
Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USA
2 shared publicationsHeba M. Amer
Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USA
2 shared publicationsOwen Whitham
Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USA
2 shared publicationsXiaoli Zhang
College of Nursing, University of South Florida, Tampa, Florida, USA
2 shared publicationsAmal O. Amer
Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USA
1 shared publication
Latest Publications
- Open Access
AI-based decoding of long covid cognitive impairments in mice using automated behavioral system and comparative transcriptomic analysis
Long COVID (LC) following SARS-CoV-2 infection affects millions of individuals world-wide and manifests with a variety of symptoms including cognitive dysfunction also known as “brain fog”. This is characterized by difficulties in executive functions, planning, decision-making, working memory, impairments in complex attention, loss of ability to learn new skills and perform sophisticated brain tasks. No effective treatment options currently exist for LC-related cognitive dysfunction. Here, we use the IntelliCage, which is an automated tracking system of cognitive functions, following SARS-CoV-2 infection in mice, measuring the ability of each mouse within a group to perform tasks that mimic complex human behaviors, such as planning, decision-making, cognitive flexibility, and working memory. Artificial intelligence and machine learning analyses of the tracking data classified LC mice into distinct behavioral categories from non-infected control mice, permitting precise identification and quantification of complex cognitive dysfunction in a controlled, replicable manner. Importantly, we find that brains from LC mice with cognitive dysfunction exhibit transcriptomic alterations similar to those observed in humans suffering from LC-related cognitive impairments, including altered expression of genes involved in learning, executive functions, synaptic functions, neurotransmitters and memory. Together, our findings establish a validated murine model and an automated unbiased approach to study LC-related cognitive dysfunction for the first time, and providing a valuable tool for screening potential treatments and therapeutic interventions.
Open AccessAI-based decoding of long covid cognitive impairments in mice using automated behavioral system and comparative transcriptomic analysis
Long COVID (LC) following SARS-CoV-2 infection affects millions of individuals world-wide and manifests with a variety of symptoms including cognitive dysfunction also known as “brain fog”. This is characterized by difficulties in executive functions, planning, decision-making, working memory, impairments in complex attention, loss of ability to learn new skills and perform sophisticated brain tasks. No effective treatment options currently exist for LC-related cognitive dysfunction. Here, we use the IntelliCage, which is an automated tracking system of cognitive functions, following SARS-CoV-2 infection in mice, measuring the ability of each mouse within a group to perform tasks that mimic complex human behaviors, such as planning, decision-making, cognitive flexibility, and working memory. Artificial intelligence and machine learning analyses of the tracking data classified LC mice into distinct behavioral categories from non-infected control mice, permitting precise identification and quantification of complex cognitive dysfunction in a controlled, replicable manner. Importantly, we find that brains from LC mice with cognitive dysfunction exhibit transcriptomic alterations similar to those observed in humans suffering from LC-related cognitive impairments, including altered expression of genes involved in learning, executive functions, synaptic functions, neurotransmitters and memory. Together, our findings establish a validated murine model and an automated unbiased approach to study LC-related cognitive dysfunction for the first time, and providing a valuable tool for screening potential treatments and therapeutic interventions.
- Open Access
- 7 May 2024
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 119, 919-944
Microglia-targeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behavior in a mouse model of Alzheimer’s disease
- 7 May 2024
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 119, 919-944
Open AccessMicroglia-targeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behavior in a mouse model of Alzheimer’s disease